Cleared Traditional

K130750 - RHYTHMIA MAPPING SYSTEM

K130750 is an FDA 510(k) clearance for RHYTHMIA MAPPING SYSTEM, manufactured by Rhythmia Medical, Inc.. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 125-day FDA review.

K130750 · Rhythmia Medical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2013
Decision
125d
Days
Class 2
Risk

K130750 is an FDA 510(k) clearance for the RHYTHMIA MAPPING SYSTEM. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Rhythmia Medical, Inc. (Burlington, US). The FDA issued a Cleared decision on July 22, 2013 after a review of 125 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Rhythmia Medical, Inc. devices

FDA 510(k) Submission Details - K130750

510(k) Number K130750 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 19, 2013
Decision Date July 22, 2013
Days to Decision 125 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
At panel average
Panel avg: 125d · This submission: 125d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 286
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K130750.
EP-WORKMATE, EP-NURSEMATE, EP-NURSEMATE WITH PHYSIO MODULE
K132073 · St Jude Medical · Sep 2013
ENSITE VELOCITY SYSTEM
K130727 · St Jude Medical · Aug 2013
SENSIS, SENSIS LITE
K131812 · Siemens Medi Cal Solutions, Inc. · Jul 2013
ENSITE VELOCITY SYSTEM
K130594 · St Jude Medical · May 2013
MAC-LAB HEMODYNAMIC RECORDING SYSTEM
K130626 · Ge Medical Systems Information Technologies, Inc. · May 2013
QUANTIEN MEASUREMENT SYSTEM
K123984 · Radi Medical Systems AB · Mar 2013